Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus intravenous iron supplementation in heart failure with iron deficiency
IRCT20180205038626N15Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ferrous sulfate and Iron in heart failure (HF), anemia of inflammation (AI) and iron deficiency anemia (IDA) (4 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: Quality of life of patients and Functional performance of patients. Started Jun 2024; status: completed.
02
Drugs
ferrous sulfateIron
03
Conditions
heart failure (HF)anemia of inflammation (AI)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on IRCT20180205038626N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180205038626N15.